Levocetirizine Eg (Levocetirizine Dihydrochloride)

Levocetirizine acts as a selective peripheral H1‑receptor antagonist. By binding to H1 receptors, it blocks histamine‑induced vasodilation, increased vascular permeability, and sensory nerve activation, thereby alleviating the typical signs of an allergic response.

The prescribed dose is determined by the treating clinician based on the patient’s age, weight, renal function and severity of symptoms. In many adult patients a common regimen is 5 mg once daily, but the exact schedule must be set by a qualified healthcare professional.

Safety data in pregnancy and lactation are limited. Levocetirizine should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levocetirizine is the active (R‑) enantiomer of cetirizine, offering similar antihistaminic efficacy with a potentially lower incidence of sedation. Both belong to the second‑generation H1‑antagonist class, but levocetirizine may provide a more favorable side‑effect profile for some patients.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain product stability.

Levocetirizine Eg is taken orally, usually as a tablet. It can be swallowed with or without food. Patients should follow the prescribing clinician’s instructions and avoid crushing or chewing the tablet unless specifically directed.

Rare but serious adverse reactions include angioedema, anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, and, in exceptional cases, cardiac arrhythmias or severe hepatic enzyme elevations. Immediate medical attention is required if any of these symptoms appear.

Patients with known hypersensitivity to levocetirizine or any component of the formulation should avoid the drug. Those with severe renal impairment should not use it without dose adjustment and close monitoring. Pregnant or breastfeeding women should only use it when clearly indicated by a healthcare professional.